U S PHYSICAL THERAPY INC /NV Quarterly Accounts Receivable, after Allowance for Credit Loss, Current in USD from Q4 2014 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.
Summary
U S Physical Therapy Inc /Nv quarterly Accounts Receivable, after Allowance for Credit Loss, Current history and growth rate from Q4 2014 to Q3 2024.
  • U S Physical Therapy Inc /Nv Accounts Receivable, after Allowance for Credit Loss, Current for the quarter ending September 30, 2024 was $57M, a 7.67% increase year-over-year.
Accounts Receivable, after Allowance for Credit Loss, Current, Quarterly (USD)
Accounts Receivable, after Allowance for Credit Loss, Current, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $57M +$4.06M +7.67% Sep 30, 2024 10-Q 2024-11-08
Q2 2024 $54.7M +$374K +0.69% Jun 30, 2024 10-Q 2024-08-14
Q1 2024 $55.4M -$1.28M -2.27% Mar 31, 2024 10-Q 2024-05-08
Q4 2023 $51.9M -$68K -0.13% Dec 31, 2023 10-Q 2024-11-08
Q3 2023 $53M +$3.21M +6.46% Sep 30, 2023 10-Q 2023-11-08
Q2 2023 $54.3M +$3.74M +7.39% Jun 30, 2023 10-Q 2023-08-09
Q1 2023 $56.6M +$7.31M +14.8% Mar 31, 2023 10-Q 2023-05-05
Q4 2022 $51.9M +$5.66M +12.2% Dec 31, 2022 10-K 2024-02-29
Q3 2022 $49.7M +$3.29M +7.08% Sep 30, 2022 10-Q 2022-11-08
Q2 2022 $50.5M +$5.41M +12% Jun 30, 2022 10-Q 2022-08-08
Q1 2022 $49.3M +$3.94M +8.68% Mar 31, 2022 10-Q 2022-05-09
Q4 2021 $46.3M +$4.37M +10.4% Dec 31, 2021 10-K 2023-02-28
Q3 2021 $46.5M +$7.02M +17.8% Sep 30, 2021 10-Q 2021-11-09
Q2 2021 $45.1M +$9.12M +25.3% Jun 30, 2021 10-Q 2021-08-09
Q1 2021 $45.4M +$2.75M +6.44% Mar 31, 2021 10-Q 2021-05-10
Q4 2020 $41.9M -$4.32M -9.35% Dec 31, 2020 10-K 2022-03-01
Q3 2020 $39.4M -$7.68M -16.3% Sep 30, 2020 10-Q 2020-11-06
Q2 2020 $36M -$8.89M -19.8% Jun 30, 2020 10-Q 2020-08-07
Q1 2020 $42.6M -$5.79M -12% Mar 31, 2020 10-Q 2020-05-21
Q4 2019 $46.2M +$1.48M +3.3% Dec 31, 2019 10-K 2021-03-01
Q3 2019 $47.1M +$3.22M +7.33% Sep 30, 2019 10-Q 2019-11-08
Q2 2019 $44.9M -$501K -1.1% Jun 30, 2019 10-Q 2019-08-09
Q1 2019 $48.4M +$2.22M +4.79% Mar 31, 2019 10-Q 2019-05-06
Q4 2018 $44.8M +$44K +0.1% Dec 31, 2018 10-K 2020-02-28
Q3 2018 $43.9M +$338K +0.78% Sep 30, 2018 10-Q 2018-11-07
Q2 2018 $45.4M -$1.35M -2.88% Jun 30, 2018 10-Q 2018-08-07
Q1 2018 $46.2M +$2.98M +6.9% Mar 31, 2018 10-Q 2018-05-07
Q4 2017 $44.7M +$5.87M +15.1% Dec 31, 2017 10-K 2019-03-18
Q3 2017 $43.6M +$5.04M +13.1% Sep 30, 2017 10-Q 2017-11-07
Q2 2017 $46.8M +$7.41M +18.8% Jun 30, 2017 10-Q 2017-08-07
Q1 2017 $43.2M +$5.03M +13.2% Mar 31, 2017 10-Q 2017-06-29
Q4 2016 $38.8M +$2.61M +7.2% Dec 31, 2016 10-K 2018-03-14
Q3 2016 $38.5M +$3.42M +9.73% Sep 30, 2016 10-K 2017-06-07
Q2 2016 $39.4M +$4.53M +13% Jun 30, 2016 10-K 2017-06-07
Q1 2016 $38.2M +$3.54M +10.2% Mar 31, 2016 10-K 2017-06-07
Q4 2015 $36.2M +$3.34M +10.2% Dec 31, 2015 10-K 2017-06-07
Q3 2015 $35.1M Sep 30, 2015 10-K 2017-06-07
Q2 2015 $34.8M Jun 30, 2015 10-K 2017-06-07
Q1 2015 $34.7M Mar 31, 2015 10-K 2017-06-07
Q4 2014 $32.9M Dec 31, 2014 10-K 2016-03-04
* An asterisk sign (*) next to the value indicates that the value is likely invalid.